K284-5752 Screening compound: 6-[6-({[(4-ethylphenyl)carbamoyl]methyl}sulfanyl)-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-7-yl]-N-[(4-methoxyphenyl)methyl]hexanamide

K284-5752 Screening compound: 6-[6-({[(4-ethylphenyl)carbamoyl]methyl}sulfanyl)-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-7-yl]-N-[(4-methoxyphenyl)methyl]hexanamide
K284-5752 Screening compound: 6-[6-({[(4-ethylphenyl)carbamoyl]methyl}sulfanyl)-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-7-yl]-N-[(4-methoxyphenyl)methyl]hexanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K284-5752
6-[6-({[(4-ethylphenyl)carbamoyl]methyl}sulfanyl)-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-7-yl]-N-[(4-methoxyphenyl)methyl]hexanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K284-5752

Molecular Formula

C33H36N4O6S (C33 H36 N4 O6 S)

Compound Name

6-[6-({[(4-ethylphenyl)carbamoyl]methyl}sulfanyl)-8-oxo-2H,7H,8H-[1,3]dioxolo[4,5-g]quinazolin-7-yl]-N-[(4-methoxyphenyl)methyl]hexanamide

IUPAC name

6-[6-({[(4-ethylphenyl)carbamoyl]methyl}sulfanyl)-8-oxo-2H7H8H-[13]dioxolo[45-g]quinazolin-7-yl]-N-[(4-methoxyphenyl)methyl]hexanamide

SMILES

CCc(cc1)ccc1NC(CSC(N1CCCCCC(NCc(cc2)ccc2OC)=O)=Nc(cc2OCOc2c2)c2C1=O)=O

InChI

InChI=1S/C33H36N4O6S/c1-3-22-8-12-24(13-9-22)35-31(39)20-44-33-36-27-18-29-28(42-21-43-29)17-26(27)32(40)37(33)16-6-4-5-7-30(38)34-19-23-10-14-25(41-2)15-11-23/h8-15,17-18H,3-7,16,19-21H2,1-2H3,(H,34,38)(H,35,39)

InChI Key

GSIZCXPYBOVJBH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15088963

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

616.74

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

16.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

5.546

Distribution Coefficient, logD

5.546

Water Solubility, LogSw

-5.20

Polar Surface Area

98.029

Acid Dissociation Constant (pKa)

12.90

Base Dissociation Constant (pKb)

-0.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

K284-5752 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with K284-5752 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K284-5752?
Check Price and Availability of K284-5752, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K284-5752 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K284-5752
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K284-5752
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K284-5752 available by request